A phase I/II trial of oxaliplatin, taxotere [docetaxel], and capecitabine in advanced adenocarcinoma of the esophagus and stomach
Latest Information Update: 30 Jul 2007
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 30 Jul 2007 New trial record.